(Q33364662)

English

Comparison of docetaxel and docetaxel-irinotecan combination as second-line chemotherapy in advanced non-small-cell lung cancer: a randomized phase II trial

scientific article

Statements

Comparison of docetaxel and docetaxel-irinotecan combination as second-line chemotherapy in advanced non-small-cell lung cancer: a randomized phase II trial (English)
1 February 2005

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit